高流量氧疗在无创通气中断时用于高碳酸血症急性呼吸衰竭恢复期患者:一项生理学交叉试验
该随机交叉生理学研究纳入30例接受无创通气超过24小时的COPD高碳酸血症急性呼吸衰竭患者,在中断无创通气时比较标准氧疗与高流量氧疗对气体交换、膈肌功能、呼吸频率和舒适度的影响。结果显示,各阶段PaCO2和pH无差异,无创通气下PaO2高于标准氧疗和高流量氧疗;膈肌位移各组无差异,但标准氧疗下膈肌增厚分数高于高流量氧疗和所有无创通气阶段,高流量氧疗与无创通气之间无差异;标准氧疗下呼吸频率增快;高流量氧疗舒适度优于标准氧疗和无创通气。
要点
- 在30例COPD高碳酸血症急性呼吸衰竭患者中断无创通气时,高流量氧疗下膈肌增厚分数与无创通气期间无差异,而标准氧疗下膈肌增厚分数显著增高(p<0.001)。
- 标准氧疗下呼吸频率较高流量氧疗(p<0.001)和无创通气(p<0.01)增加。
- 高流量氧疗舒适度优于标准氧疗(p=0.004)和无创通气(p<0.001)。
- PaCO2(p=0.153)和pH(p=0.114)在各试验阶段无差异;无创通气下PaO2高于标准氧疗(p≤0.005)和高流量氧疗(p≤0.001)。
- 膈肌位移在各试验阶段无差异(p=0.875)。
适用人群与场景
- 30例COPD高碳酸血症急性呼吸衰竭患者,接受无创通气大于24小时。
- 研究在2个ICU进行。
处置流程与药物剂量
- 所有患者接受5个30分钟试验阶段:第1、3、5阶段为无创通气,第2、4阶段随机采用标准氧疗或高流量氧疗。
- 在每个试验阶段结束时通过超声评估膈肌位移和增厚分数,并评估动脉血气、呼吸频率和患者舒适度。
研究设计与关键结果
- 随机交叉生理学研究,纳入30例COPD高碳酸血症急性呼吸衰竭患者,在2个ICU进行。
- PaCO2(p=0.153)和pH(p=0.114)在各试验阶段无差异;PaO2在无创通气下高于标准氧疗(p≤0.005)和高流量氧疗(p≤0.001)。
- 膈肌位移在各试验阶段无差异(p=0.875);膈肌增厚分数在标准氧疗下高于高流量氧疗和所有无创通气阶段(所有比较p<0.001),高流量氧疗与无创通气之间无差异。
- 呼吸频率在标准氧疗下较高流量氧疗(p<0.001)和无创通气(p<0.01)增加。
- 高流量氧疗舒适度优于标准氧疗(p=0.004)和无创通气(p<0.001)。
证据类型、等级与局限
- 证据类型:随机交叉生理学研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在COPD高碳酸血症急性呼吸衰竭患者接受无创通气大于24小时后中断无创通气时,高流量氧疗可维持膈肌增厚分数不变并改善舒适度,而标准氧疗下膈肌增厚分数明显增加且呼吸频率增快。
- 作者认为,中断无创通气时无论采用何种氧疗方式,PaCO2和膈肌位移保持不变;高流量氧疗维持膈肌增厚分数不变并改善患者舒适度。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Assessing gas exchange, diaphragm function, respiratory rate, and patient comfort during high-flow oxygen therapy and standard oxygen at the time of noninvasive ventilation discontinuation.
DESIGN: Randomized crossover physiologic study.
PATIENTS: Thirty chronic obstructive pulmonary disease patients with hypercapnic acute respiratory failure receiving noninvasive ventilation greater than 24 hours.
INTERVENTIONS: All patients underwent five 30-minute trials, the first, third, and fifth trial in noninvasive ventilation, whereas the second and fourth were randomly conducted with either standard oxygen and high-flow oxygen therapy.
MEASUREMENTS AND MAIN RESULTS: Diaphragm displacement and thickening fraction were determined by sonographic evaluation at the end of each trial. Arterial blood gases, respiratory rate, and patient comfort were also assessed. PaCO2 (p = 0.153) and pH (p = 0.114) were not different among trials, while PaO2 was greater in noninvasive ventilation than with both standard oxygen (p ≤ 0.005) and high-flow oxygen therapy (p ≤ 0.001). The diaphragm displacement was no different among trials (p = 0.875), while its thickening fraction was greater with standard oxygen, compared with high-flow oxygen therapy and all noninvasive ventilation trials (p < 0.001 for all comparisons), without differences between high-flow oxygen therapy and noninvasive ventilation. Respiratory rate also increased with standard oxygen, compared with both high-flow oxygen therapy (p < 0.001) and noninvasive ventilation (p < 0.01). High-flow oxygen therapy improved comfort, compared with standard oxygen (p = 0.004) and noninvasive ventilation (p < 0.001).
CONCLUSIONS: At the time of noninvasive ventilation interruption, PaCO2 and diaphragm displacement remained unchanged regardless of the modality of oxygen administration. However, although standard oxygen resulted in a remarkable increase in diaphragm thickening fraction, high-flow oxygen therapy allowed maintaining it unchanged, while improving patient comfort.
参考来源
- Longhini F, Pisani L, Lungu R, et al. High-Flow Oxygen Therapy After Noninvasive Ventilation Interruption in Patients Recovering From Hypercapnic Acute Respiratory Failure: A Physiological Crossover Trial. Crit Care Med. 2019. PMID: 30882477. doi:10.1097/CCM.0000000000003740
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。